Does TALIMOGENE LAHERPAREPVEC Cause Off label use? 196 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Off label use have been filed in association with TALIMOGENE LAHERPAREPVEC (Imlygic). This represents 13.3% of all adverse event reports for TALIMOGENE LAHERPAREPVEC.
196
Reports of Off label use with TALIMOGENE LAHERPAREPVEC
13.3%
of all TALIMOGENE LAHERPAREPVEC reports
25
Deaths
25
Hospitalizations
How Dangerous Is Off label use From TALIMOGENE LAHERPAREPVEC?
Of the 196 reports, 25 (12.8%) resulted in death, 25 (12.8%) required hospitalization, and 4 (2.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALIMOGENE LAHERPAREPVEC. However, 196 reports have been filed with the FAERS database.
What Other Side Effects Does TALIMOGENE LAHERPAREPVEC Cause?
Pyrexia (135)
Product storage error (133)
Metastatic malignant melanoma (109)
Circumstance or information capable of leading to medication error (89)
Death (82)
Influenza like illness (82)
Fatigue (70)
Chills (68)
Malignant melanoma (64)
Therapy partial responder (56)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TALIMOGENE LAHERPAREPVEC Alternatives Have Lower Off label use Risk?
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB-TGVS
TALIMOGENE LAHERPAREPVEC vs TAMIFLU
TALIMOGENE LAHERPAREPVEC vs TAMOXIFEN
TALIMOGENE LAHERPAREPVEC vs TAMSULOSIN